Applied DNA Sciences, Inc.
APDN · NASDAQ
9/30/2025 | 9/30/2024 | 9/30/2023 | 9/30/2022 | |
|---|---|---|---|---|
| Market Cap | $0 | $2 | $12 | $8 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $0 | $2 | $12 | $8 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | -37.7% | -74.3% | -26.4% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 39.3% | 29.6% | 41.4% | 27.8% |
| EBITDA | -$0 | -$0 | -$0 | -$0 |
| % Margin | -750.9% | -388.4% | -71.7% | -69.8% |
| Net Income | -$0 | -$0 | -$0 | -$0 |
| % Margin | -3,251.7% | -203.8% | -74.4% | -46.1% |
| EPS Diluted | -134.23 | -1.82 | -15.21 | -18.68 |
| % Growth | -7,275.3% | 88% | 18.6% | – |
| Operating Cash Flow | -$0 | -$0 | -$0 | -$0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | -$0 | -$0 | -$0 | -$0 |